NanoViricides, Inc. (NNVC) Financials
NNVC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 9.9 trillion | 1.2 trillion |
| March 31, 2026 | 10.2 million | 1.1 million |
| Dec. 31, 2025 | 12.3 million | 1.2 million |
| Sept. 30, 2025 | 8.4 million | 1.2 million |
NNVC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 3.2 trillion | -125.0 million |
| March 31, 2026 | -1.9 million | 71127 |
| Dec. 31, 2025 | -2.0 million | 196684 |
| Sept. 30, 2025 | -1.7 million | 49882 |
NNVC Net Income
No data available :(
NNVC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 2.8 trillion | - | - |
| March 31, 2026 | 3.2 million | - | - |
| Dec. 31, 2025 | 5.2 million | - | - |
| Sept. 30, 2025 | 1.1 million | - | - |
NNVC Shares Outstanding
NNVC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 84.3 billion | 1.3 trillion | 2.9 trillion | - |
| March 31, 2026 | 2 | 1.3 trillion | 744.3 billion | - |
| Dec. 31, 2025 | 1 | 1.1 million | 1.1 million | - |
| Sept. 30, 2025 | 84315 | 993066 | 803619 | - |
NNVC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 129749 |
| March 31, 2026 | - | 129633 |
| Dec. 31, 2025 | - | 133084 |
| Sept. 30, 2025 | - | 132820 |
NNVC
Price: $1.35
52 week price:
Earnings Per Share: -0.41 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 10400
Market Capitalization: 33.2 million